RHE RSI Chart
Last 7 days
-3.5%
Last 30 days
-4.5%
Last 90 days
-0.4%
Trailing 12 Months
-20.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 17.4M | 0 | 0 | 0 |
2023 | 33.2M | 29.7M | 22.8M | 17.2M |
2022 | 26.3M | 27.9M | 32.2M | 35.9M |
2021 | 20.1M | 22.0M | 24.0M | 26.7M |
2020 | 19.3M | 18.5M | 18.4M | 17.6M |
2019 | 21.5M | 21.5M | 21.0M | 20.1M |
2018 | 25.0M | 24.0M | 22.9M | 22.0M |
2017 | 26.7M | 25.8M | 25.0M | 25.1M |
2016 | 23.9M | 26.6M | 27.7M | 27.6M |
2015 | 7.1M | 10.9M | 14.6M | 18.4M |
2014 | 179.0M | 144.2M | 95.6M | 3.3M |
2013 | 206.8M | 209.8M | 210.3M | 186.3M |
2012 | 154.0M | 171.4M | 184.1M | 198.9M |
2011 | 72.6M | 94.5M | 116.4M | 138.2M |
2010 | 0 | 0 | 0 | 50.8M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 30, 2023 | morrison brent | bought | 2,805 | 2.75 | 1,020 | ceo and president |
Aug 29, 2023 | morrison brent | bought | 100 | 2.71 | 37.00 | ceo and president |
Aug 28, 2023 | morrison brent | bought | 737 | 2.75 | 268 | ceo and president |
Aug 25, 2023 | morrison brent | bought | 2,519 | 2.66 | 947 | ceo and president |
Aug 25, 2023 | o'sullivan paul jason | bought | 2,690 | 2.69 | 1,000 | senior vice president |
Aug 24, 2023 | o'sullivan paul jason | bought | 7,025 | 2.81 | 2,500 | senior vice president |
Feb 16, 2022 | waites benjamin a | sold (taxes) | -12,772 | 4.51 | -2,832 | chief financial officer |
Feb 16, 2022 | morrison brent | sold (taxes) | -12,772 | 4.51 | -2,832 | ceo and president |
Jan 01, 2022 | morrison brent | acquired | - | - | 24,000 | ceo and president |
Aug 31, 2021 | tenwick david a | sold | -23,000 | 11.5 | -2,000 | - |
Which funds bought or sold RHE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 15, 2024 | BANK OF AMERICA CORP /DE/ | new | - | 37.00 | 37.00 | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 3.79 | 474 | 2,347 | -% |
May 13, 2024 | FMR LLC | sold off | -100 | -5.00 | - | -% |
May 13, 2024 | UBS Group AG | new | - | 125 | 125 | -% |
May 10, 2024 | WELLS FARGO & COMPANY/MN | reduced | -0.1 | 425 | 2,484 | -% |
May 10, 2024 | CITIGROUP INC | unchanged | - | - | 2.00 | -% |
May 10, 2024 | VANGUARD GROUP INC | unchanged | - | 7,149 | 41,576 | -% |
May 09, 2024 | BARTLETT & CO. WEALTH MANAGEMENT LLC | unchanged | - | 50.00 | 336 | -% |
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Jan 08, 2024 | Bartlett & Co. LLC | unchanged | - | - | - | -% |
Unveiling Regional Health Properties Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Regional Health Properties Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.43 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
Regional Health Properties Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -8.7% | 4,127 | 4,522 | 4,138 | 4,598 | 3,906 | 10,155 | 11,030 | 8,093 | 6,648 | 6,439 | 6,702 | 6,468 | 7,081 | 3,725 | 4,767 | 4,539 | 4,548 | 4,579 | 4,830 | 5,301 | 5,424 |
Operating Expenses | 1.3% | 4,421 | 4,363 | 4,542 | 4,412 | 4,651 | 13,129 | 13,001 | 8,622 | 7,987 | 6,107 | 6,096 | 5,982 | 5,966 | 4,024 | 4,137 | 3,458 | 3,666 | 3,380 | 3,538 | 3,684 | 4,070 |
S&GA Expenses | -100.0% | - | 787 | 972 | 1,011 | 1,206 | 1,225 | 1,378 | 921 | 1,123 | 960 | 980 | 952 | 1,036 | 1,039 | 743 | 714 | 877 | 641 | 730 | 895 | 926 |
EBITDA Margin | -1.4% | 0.22* | 0.23* | 0.17* | 0.13* | 0.11* | 0.11* | 0.12* | 0.14* | 0.15* | 0.15* | 0.16* | 0.18* | 0.24* | - | - | - | - | - | - | - | - |
Interest Expenses | -1.5% | 674 | 685 | 708 | 679 | 680 | 674 | 564 | 639 | 653 | 647 | 669 | 666 | 687 | 686 | 692 | 684 | 715 | 730 | 1,157 | 1,724 | 1,654 |
Income Taxes | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -44.00 | - | - | 44.00 |
Earnings Before Taxes | - | - | - | - | - | - | - | - | - | - | -713 | -17.00 | -441 | 34.00 | -962 | -71.00 | 406 | 23.00 | 489 | 5,710 | -1,375 | 50.00 |
EBT Margin | 1.3% | -0.07* | -0.07* | -0.05* | -0.04* | -0.03* | -0.03* | -0.04* | -0.04* | -0.04* | -0.04* | -0.06* | -0.07* | -0.03* | - | - | - | - | - | - | - | - |
Net Income | -304.2% | -962 | -238 | -973 | -685 | -1,992 | -2,244 | -371 | -1,325 | -2,927 | -661 | -39.00 | -503 | 21.00 | -1,013 | -73.00 | 412 | -14.00 | 748 | 5,811 | -1,243 | 184 |
Net Income Margin | 27.4% | -0.16* | -0.23* | -0.26* | -0.18* | -0.18* | -0.19* | -0.16* | -0.18* | -0.16* | -0.04* | -0.06* | -0.07* | -0.03* | - | - | - | - | - | - | - | - |
Free Cashflow | 159.5% | 545 | 210 | 398 | -449 | 2,595 | -1,523 | 596 | -1,291 | -1,659 | 778 | 1,680 | -4.00 | 2,317 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -1.5% | 61.00 | 62.00 | 64.00 | 66.00 | 66.00 | 69.00 | 95.00 | 100 | 103 | 106 | 107 | 107 | 109 | 108 | 110 | 112 | 112 | 114 | 114 | 135 | 137 |
Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 6.00 | 26.00 | 5.00 |
Cash Equivalents | -5.0% | 4.00 | 4.00 | 5.00 | 5.00 | 6.00 | 4.00 | 5.00 | 6.00 | 8.00 | 10.00 | 10.00 | 9.00 | 9.00 | 7.00 | 8.00 | 7.00 | 7.00 | 8.00 | 7.00 | 5.00 | 5.00 |
Net PPE | -1.0% | 45.00 | 45.00 | 46.00 | 46.00 | 46.00 | 47.00 | 49.00 | 49.00 | 50.00 | 50.00 | 51.00 | 51.00 | 52.00 | 53.00 | 53.00 | 54.00 | 54.00 | 55.00 | 56.00 | 56.00 | 76.00 |
Goodwill | 0% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Liabilities | -0.1% | 62.00 | 62.00 | 64.00 | 65.00 | 64.00 | 65.00 | 90.00 | 93.00 | 95.00 | 95.00 | 96.00 | 96.00 | 98.00 | 97.00 | 98.00 | 100 | 101 | 102 | 103 | 130 | 130 |
Current Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.00 | 40.00 | 39.00 |
Shareholder's Equity | -496.8% | -0.73 | 0.00 | 0.00 | 1.00 | 2.00 | 4.00 | 6.00 | 6.00 | 8.00 | 10.00 | 11.00 | 11.00 | 11.00 | 11.00 | 12.00 | 12.00 | 12.00 | 12.00 | 11.00 | 5.00 | 6.00 |
Retained Earnings | -1.2% | -82.86 | -81.90 | -81.66 | -80.69 | -123 | -121 | -119 | -118 | -117 | -114 | -113 | -113 | -113 | -113 | -112 | -112 | -112 | -112 | -113 | -119 | -117 |
Shares Outstanding | 0.0% | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 6.00 | - | - | - | 0.00 | - | - | - | 21.00 | - | - | - | 3.00 | - | - | - | 3.00 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 138.1% | 600 | 252 | 460 | 403 | 2,597 | -1,425 | 627 | -1,219 | -1,579 | 782 | 1,725 | 37.00 | 2,350 | 379 | 1,000 | 51.00 | -135 | 1,211 | 750 | 600 | -165 |
Share Based Compensation | 19.4% | 43.00 | 36.00 | 85.00 | 155 | 81.00 | 60.00 | 58.00 | 4.00 | 111 | 179 | 179 | - | - | 12.00 | 13.00 | 12.00 | 12.00 | 22.00 | 22.00 | 21.00 | 27.00 |
Cashflow From Investing | -31.0% | -55.00 | -42.00 | -62.00 | -852 | -2.00 | -98.00 | -31.00 | -72.00 | -80.00 | -4.00 | -45.00 | -41.00 | -33.00 | -241 | -52.00 | - | -157 | 185 | 2,539 | -8.00 | 1,105 |
Cashflow From Financing | -13.6% | -751 | -661 | -673 | -460 | -685 | 35.00 | -723 | -701 | -673 | -556 | -653 | -584 | -622 | -392 | -379 | -184 | -436 | -448 | -1,054 | -1,010 | -2,153 |
Buy Backs | - | - | - | - | - | - | - | - | - | 46.00 | - | - | - | - | - | - | - | - | - | - | - | - |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenues: | ||
Total revenues | $ 4,127 | $ 3,906 |
Expenses: | ||
Patient care expense | 2,101 | 2,321 |
Facility rent expense | 149 | 149 |
Cost of management fees | 0 | 141 |
Depreciation and amortization | 511 | 510 |
General and administrative expense | 1,632 | 1,531 |
Doubtful accounts expense | 28 | 16 |
Total expenses | 4,421 | 4,668 |
Loss from operations | (294) | (762) |
Other expense: | ||
Interest expense, net | 674 | 680 |
Other (income) expense, net | (6) | 550 |
Total other expense, net | 668 | 1,230 |
Net Loss | (962) | (1,992) |
Preferred stock dividends - undeclared | 0 | (2,249) |
Net loss attributable to Regional Health Properties, Inc. common stockholders | $ (962) | $ (4,241) |
Net loss per share of common stock attributable to Regional Health Properties, Inc., Basic | $ (0.52) | $ (2.28) |
Net loss per share of common stock attributable to Regional Health Properties, Inc., Diluted | $ (0.52) | $ (2.28) |
Weighted average shares of common stock outstanding: | ||
Basic (in shares) | 1,839 | 1,862 |
Diluted (in shares) | 1,839 | 1,862 |
Patient Care Revenues | ||
Revenues: | ||
Patient care, management fees and other revenues | $ 2,309 | $ 1,916 |
Total revenues | 2,309 | 1,916 |
Rental Revenue | ||
Revenues: | ||
Patient care, management fees and other revenues | 1,818 | 1,708 |
Management Fees | ||
Revenues: | ||
Patient care, management fees and other revenues | 0 | 278 |
Total revenues | 278 | |
Other Revenues | ||
Revenues: | ||
Patient care, management fees and other revenues | $ 0 | 4 |
Total revenues | $ 4 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
ASSETS | ||
Property and equipment, net | $ 44,885 | $ 45,337 |
Cash | 752 | 953 |
Restricted cash | 3,223 | 3,231 |
Accounts receivable, net of allowances of $2,056 and $2,040 | 1,464 | 1,403 |
Prepaid expenses and other | 410 | 609 |
Notes receivable | 1,034 | 1,044 |
Intangible assets - bed licenses | 2,471 | 2,471 |
Intangible assets - lease rights, net | 83 | 87 |
Right-of-use operating lease assets | 2,455 | 2,556 |
Goodwill | 1,585 | 1,585 |
Lease deposits and other deposits | 4 | 4 |
Straight-line rent receivable | 2,859 | 2,901 |
Total assets | 61,225 | 62,181 |
LIABILITIES AND EQUITY (DEFICIT) | ||
Senior debt, net | 43,500 | 43,855 |
Bonds, net | 5,993 | 5,991 |
Other debt, net | 516 | 889 |
Accounts payable | 3,106 | 2,493 |
Accrued expenses | 4,240 | 4,060 |
Operating lease obligation | 2,807 | 2,917 |
Other liabilities | 1,797 | 1,791 |
Total liabilities | 61,959 | 61,996 |
Stockholders' equity (deficit): | ||
Common stock and additional paid-in capital, no par value; 55,000 shares authorized; 1,850 shares issued and 1,839 shares outstanding at March 31, 2024 and December 31, 2023 | 63,102 | 63,059 |
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: | ||
Accumulated deficit | (82,864) | (81,902) |
Total stockholders' equity (deficit) | (734) | 185 |
Total liabilities and stockholders' equity (deficit) | 61,225 | 62,181 |
Series A Preferred Stock | ||
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: | ||
Preferred stock | 426 | 426 |
Series B Preferred Stock | ||
Preferred stock, no par value; 5,000 shares authorized (including amounts authorized for Series A and Series B); shares issued and outstanding designated as follows: | ||
Preferred stock | $ 18,602 | $ 18,602 |